000 | 01388 a2200409 4500 | ||
---|---|---|---|
005 | 20250516064316.0 | ||
264 | 0 | _c20120125 | |
008 | 201201s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/WNL.0b013e31823a0cb6 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatthews, E | |
245 | 0 | 0 |
_aAcetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype. _h[electronic resource] |
260 |
_bNeurology _cNov 2011 |
||
300 |
_a1960-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetazolamide _xpharmacology |
650 | 0 | 4 |
_aCarbonic Anhydrase Inhibitors _xpharmacology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypokalemic Periodic Paralysis _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aPortaro, S | |
700 | 1 | _aKe, Q | |
700 | 1 | _aSud, R | |
700 | 1 | _aHaworth, A | |
700 | 1 | _aDavis, M B | |
700 | 1 | _aGriggs, R C | |
700 | 1 | _aHanna, M G | |
773 | 0 |
_tNeurology _gvol. 77 _gno. 22 _gp. 1960-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e31823a0cb6 _zAvailable from publisher's website |
999 |
_c21322026 _d21322026 |